Peptides for Weight Loss: What Should Women Know Before Getting Started?

Written by Julie Salter, NASM-certified personal trainer and nutrition coach, Founder of Julie Salter Fitness. About Julie: https://juliesalterfitness.com/about-the-ceo
Published: September 8, 2026.

Weight-loss peptides are lab-made versions of a gut hormone called GLP-1. The two most common are semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Mounjaro and Zepbound. Both are prescription medications that lower appetite and slow digestion, and both require real medical oversight, not a self-start.

If you're reading this because a friend lost weight on one of these, your doctor brought it up, or you're simply tired of starting over every Monday, you're in the right place. I'm not going to tell you peptides are a shortcut or a scam.

They're neither. Here's what I actually want you to know before you book anything.

This matters most if you're already tired of restrictive diets, you're in midlife or menopause wondering if the old rules still apply, or you're comparing your options honestly before you spend any money. You don't need to have decided anything yet.

Researching before you commit to anything is the right instinct. I want to reward it with a straight answer, not a pitch.

There's a version of this article that tries to sell you on peptides, and one that tries to scare you off them. This isn't either one. It's the version I'd want a friend to hand me before I booked a consultation.

What exactly are weight-loss peptides, and how are they different from older diet drugs?

A peptide is a short chain of amino acids, the same building blocks in every protein in your body. Your body already produces GLP-1 naturally, in your gut, every time you eat. GLP-1 stands for glucagon-like peptide-1, one of the signals that tells your brain you're full.

Semaglutide and tirzepatide are both GLP-1 receptor agonists. They act like your natural GLP-1, but stay active in your system far longer. They attach to receptors in the brain regions that control hunger and fullness, mainly the hypothalamus and brainstem.

That combination slows digestion and reduces hunger, so you can eat less without having to white-knuckle it, according to Mayo Clinic's explanation of how semaglutide works (https://diet.mayoclinic.org/us/blog/2024/how-does-semaglutide-work/). Tirzepatide goes one step further and also activates a second gut-hormone receptor, called GIP, part of why it tends to produce larger results in head-to-head trials.

One source of confusion worth clearing up: Ozempic and Wegovy are the same drug, semaglutide, approved under different names for different doses and uses. The same is true of Mounjaro and Zepbound with tirzepatide.

Your provider isn't offering something different by suggesting one brand over another. They're usually navigating dosing, insurance coverage, and what's actually in stock.

This isn't a brand-new class of drug. The first GLP-1 receptor agonist was approved for diabetes back in 2005 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11944337/), and the class has been studied in people with diabetes for two decades.

Weight loss at higher doses is the newer part of the story. The mechanism itself, not the marketing around it, has a long track record.

This is a different mechanism than older diet pills like phentermine, which act more like a stimulant, raising heart rate and adrenaline to blunt appetite. That's a big part of why peptides feel different to take day to day. Most women describe quieter, steadier hunger, not the jittery suppression older diet drugs caused.

Peptides don't make your body burn more calories at rest. They make it easier to eat fewer, without spending your whole day fighting your own hunger.

One more distinction worth making: real GLP-1 peptides are prescription drugs, not the "peptide" supplements sold on some wellness shelves. Those over-the-counter products are a different category entirely, and they aren't the same thing this article is about.

Most weight-loss peptides are given as a once-weekly injection you learn to do yourself, though an oral form of semaglutide exists too. Your provider typically starts you on the lowest dose and raises it slowly over weeks, sometimes months.

That gradual pace isn't a delay tactic. It keeps side effects manageable and shows your provider the smallest dose that actually works for you.

Are peptides for weight loss safe, and who shouldn't use them?

For most healthy adults, yes. Stanford Medicine reports that these medications have been through large clinical trials, hold FDA approval, and have been prescribed for diabetes for more than twenty years (https://med.stanford.edu/news/insights/2026/06/glp1s-101-weight-loss-wegovy-ozempic-zepbound-side-effects-safe-use.html).

But safe for most women doesn't mean automatically safe for you. Mayo Clinic lists real exclusions (https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955): a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia, a history of pancreatitis, pregnancy, or breastfeeding.

Certain digestive conditions, like gastroparesis, and some kidney disease can also change the picture. That's exactly why a real screening with a licensed provider matters more than a quick online questionnaire.

A joint clinical advisory that includes the Obesity Medicine Association recommends a genuine baseline screening before anyone starts GLP-1 therapy (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304835/), not just a form to fill out. That screening is a standard, not an extra step.

The most common side effects show up early: nausea, constipation, or an upset stomach while your body adjusts. For most women, these settle within a few weeks.

Going slower through dose increases, and easing off heavy meals for a few days after a change, tends to help. None of that is medical advice specific to you, it's simply what your prescribing provider should walk you through directly.

You may also see these medications carry a boxed warning, the FDA's strongest label warning, related to thyroid tumors seen in animal studies. That hasn't been confirmed as a risk in humans, but it's taken seriously out of caution.

Mild nausea in week one is common and expected. Severe abdominal pain, signs of a serious allergic reaction, or anything that feels genuinely wrong is not something to wait out, that's what your provider's phone number is for.

There's also a real difference between a brand-name, FDA-approved product from a licensed pharmacy and a compounded version from a compounding pharmacy. For a stretch of the last few years, both semaglutide and tirzepatide sat on the FDA's drug shortage list, which is exactly what let compounding pharmacies legally copy them.

Once the FDA decided the shortage was over, that legal exception started closing. Regulators have been tightening oversight of compounded GLP-1 products for more than a year (https://med.stanford.edu/news/insights/2026/07/glp1s-compounded-why-doctors-worry-about-safety.html), and in 2026 the FDA proposed closing most of the remaining legal compounding pathways (https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list).

That's one more reason to work through physician-coordinated care rather than sourcing this on your own from a site or ad you found online.

At Julie Salter Fitness, peptide and metabolic support is offered through a licensed medical team. It's never required, and it's not where anyone starts.

Safe for many women doesn't mean automatically safe for you. That's what a real screening is for.

Most women without one of those specific red flags, working with a provider who checks history properly, are reasonable candidates from a safety standpoint. Being a safe candidate and needing this are different questions, and a real assessment should cover both.

What results are realistic in the first three to six months?

Results vary, and anyone promising an exact number before they know your history is guessing. Real-world data still gives a useful, honest range.

In one large study out of an academic obesity clinic, published through NIH's National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515774/), patients who stayed on semaglutide or tirzepatide for at least six months lost a median of about 9 percent of their starting weight. Those who stayed on it a full year lost closer to 14 percent, though results ranged widely.

Weight loss on these medications is rarely a straight line. Most women notice the biggest early shift in appetite within the first few weeks.

The number on the scale tends to move more steadily across months two through six, as the dose slowly increases. Plateaus during a dose hold are common and aren't a sign anything has failed.

One thing rarely gets said out loud. Weight regain tends to climb quickly in the first three to four months after stopping the medication (https://clinicaltrials.gov/study/NCT06273163), if nothing else about your habits has changed.

That's not a reason to avoid peptides. It's the exact reason nutrition and strength coaching matter alongside them, which we'll get to below.

Cost is part of realistic planning too, and it's worth being honest about upfront. These medications aren't cheap, and coverage varies enormously by insurance plan, diagnosis, and even which pharmacy fills it.

Some plans cover them fully for diabetes and barely at all for weight loss alone. Others require you to try and fail other approaches first.

Before you commit to anything, ask for the total monthly cost, not just the medication price, and what happens if insurance denies coverage.

The scale is one measurement, not the whole story. Energy, sleep quality, how your clothes fit, and how you feel walking up a flight of stairs all move too, often before the number does.

The medication changes your biology. What you do with the extra room it gives you decides what happens after.

It's worth saying plainly: none of this is about willpower. If a friend loses more weight than you on the same medication, that's not about who's trying harder. Dose, biology, sleep, stress, and consistency all move the number.

Do I need a prescription, and how does medical oversight actually work?

Yes. Every legitimate path to semaglutide or tirzepatide, brand-name or the shrinking compounded options, requires a prescription from a licensed provider who has actually reviewed your history.

This isn't a place for shortcuts, and with the FDA closing off both legal compounding pathways this year (https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list), the shortcuts that used to exist are disappearing anyway.

Here's where I want to be clear about what coaching is and isn't, because the line matters. Coaching supports your habits, your nutrition, your training, your planning, and your accountability.

Coaching does not diagnose you, prescribe anything, choose your dose, change your medication, direct a taper, or interpret your lab work. That's medical care, and it deserves an actual clinician, not an app guessing on your behalf.

If you decide to move forward, real medical oversight looks like an actual person reviewing your full history and choosing a starting dose with you, not for you. They check in as your dose changes and stay reachable if something feels wrong.

This holds true whether care happens over telehealth or in person. Telehealth itself isn't the problem, plenty of women get excellent, well-monitored care that way.

The problem is a workflow built to write as many prescriptions as possible, as fast as possible. A fair question for any provider: what happens if I have a side effect at 9pm on a Friday, and who actually answers?

A prescription without a real relationship with the person writing it isn't medical oversight. It's a transaction.

Coaching alongside your medication is a separate cost from the medication itself, and it's fair to ask exactly what that includes before you sign up for anything. A real program should be able to tell you plainly.

When Julie Salter Fitness coordinates peptide and metabolic support, it works alongside a licensed medical team rather than replacing one. That's what medically supervised weight loss should look like: physician-coordinated care on one side, coaching on the other.

The prescribing and dosing decisions stay with the clinician who actually has your chart.

Why does nutrition and coaching matter if the medication already handles my appetite?

Because appetite suppression isn't the same thing as a plan.

When you eat less without changing what you eat, a meaningful share of what comes off can be muscle, not just fat. That risk is real enough that we wrote an entire piece on it: Does Semaglutide Cause Muscle Loss? Here's What to Know (https://juliesalterfitness.com/post/semaglutide-muscle-loss).

Protein intake and resistance training aren't optional extras on a GLP-1 medication. They're how you protect the body you're actually trying to build, not just the number on the scale.

In practice that means two shifts: eating enough protein at meals you may not feel hungry for anymore, and strength training two or three times a week. Neither is about punishment, it's about giving your body a reason to hold onto muscle while the deficit does its work.

For women in the 35-to-60 range, hormones are already shifting the rules on their own, medication or not. If you're navigating perimenopause or menopause, the medication is only addressing one piece of a bigger picture: sleep, stress, and strength.

Poor sleep and chronic stress push on the same hunger and blood-sugar systems a GLP-1 medication is trying to calm. That's part of why two women on the same dose can have very different experiences.

Our piece on why weight loss gets harder in menopause (https://juliesalterfitness.com/post/why-cant-i-lose-weight-in-menopause) walks through the rest of it.

This is exactly why I built something called the 4B Approach. Appetite control was never the whole story for the women I coach, medication or not.

Biology is what your hormones, thyroid, metabolism, sleep, and digestion are actually doing, on or off medication. You can't out-discipline a system that's working against you.

Behavior is the skills, so you stop guessing: training that builds you instead of draining you, food you can actually eat on a real Tuesday.

Belief is who you are on the hard days, not mindset. Mindset is the story you tell when things are going well, belief is what you do when they're not.

That might look like eating the birthday cake and getting right back to your plan the next meal, instead of writing off the whole week. The medication can quiet your hunger. It can't make that decision for you.

Bandwidth is making it hold in the life you're actually living: the busy season, the sick kid, the travel, the weeks that fall apart. Most plans are built for a life with nothing else in it, yours gets built for the one you're living.

Somewhere after thirty, your body changes the rules. I teach women the new ones.

Appetite suppression buys you quiet. What you build in that quiet is what lasts.

None of this is meant to talk you into or out of anything. Some women do well building strength and nutrition habits on their own, others do better with medical support alongside that work.

Both are legitimate paths, neither is the "real" way to lose weight. What I care about is that you choose yours with real information, not a headline or a friend's before-and-after photo.

Do less. Eat more. Lose weight for good.

That's true whether a peptide is part of your plan or not. The medication, if you choose one, is a tool. What you build around it is still yours.

More to read: why weight loss gets harder in menopause (https://juliesalterfitness.com/post/why-cant-i-lose-weight-in-menopause), does semaglutide cause muscle loss (https://juliesalterfitness.com/post/semaglutide-muscle-loss), and what body recomposition actually means for women (https://juliesalterfitness.com/post/body-recomposition-for-women).